Skip to main content
. 2017 May 15;12:1457–1468. doi: 10.2147/COPD.S130713

Figure 4.

Figure 4

Percentage reduction in time to discontinuation for budesonide/formoterol compared with formoterol according to COPD disease severity.

Notes: Data are presented with 95% confidence intervals. Four discontinuations (three on formoterol and one on budesonide/formoterol) at 1 month in patients with moderate COPD.